Abstract:Background: Non-small cell lung cancer (NSCLC) is the most common histological type of lung cancer, and one of the malignant tumor with the highest mortality. As the main part of the optical molecular imaging probe, peptide can realize the early screening and diagnosis of tumor and improve the survival rate of patients. The aim of this study was to screen the small-molecule peptide that highly binds to NSCLC NCI-H1299 cells using in vivo phage display technology and to identify their binding specificity by in vitro experiment. Methods: To prepare a tumor-bearing nude mouse model of NCI-H1299 cells, after 3 rounds of in vivo screening with Ph.D.-C7CTM Peptide Library, phage clones were randomly picked, using immunohistochemistry and enzyme-linked immunosorbent assay (ELISA) to identify the affinity of phage clones to NCI-H1299 cells. The positive monoclonal phages DNA was extracted and sequenced to obtain the amino acid sequence of the peptides. The peptides with the highest repetition rate was chemically synthesized and labeled with fluorescein (FITC) to prepare optical molecular probe. We preliminary identified the specificity of the probe binding to lung cancer cells by in vitro experiment. Results: After three rounds of in vivo screening, the phages enrichment rate was 341.3 times compared with the first round. Immunohistochemical staining showed that with the increase of screening times, the phages binding to tumor tissues continued to increase, and the binding amount was significantly higher than normal tissues; ELISA results showed that 20 clones among the 30 randomly selected phage clones were positive. After sequencing, the peptide with the highest repetition rate was synthesized and named NSP1; Methyl thiazolyl tetrazolium assay (MTT) and would healing assay showed that NSP1 will not affect cell proliferation and migration. Flow cytometry and immunofluorescence showed specific binding of NSP1 to NCI-H1299 cells. Conclusions: We successfully obtained the peptide NSP1 that specifically binds to lung cancer NCI-H1299 cells by in vivo phage display, which provide a theoretical basis for NSCLC early diagnosis and targeted therapy.

Panning and identification of lung cancer cell line NCI-H1299 specific peptide from a phage display peptide library

Screening of Lung Cancer Specific Peptide ZS-9 from a Phage Display Peptide Library and NCI-H1299 Cells

[Screening and Identification of the Peptides Specifically Binding to Human Non-small Cell Lung Cancer NCI-H1299 Cells]

Screening and Identification of A Targeting Peptide to Hepatocarcinoma from A Phage Display Peptide Library

Screening and identification of hepatocellular carcinoma cell specific binding peptides using phage display peptide library

Panning and Identification of a Colon Tumor Binding Peptide from a Phage Display Peptide Library

Ribosome Display System Combine Lung Cancer Cell Screening Up Specific Anti- Lung Cancer Cell Peptides

Screening and Identification of a Renal Carcinoma Specific Peptide from a Phage Display Peptide Library

Identification of a peptide binding to cancer antigen Kita‐kyushu lung cancer antigen 1 from a phage‐display library

Selection and Preliminary Identification of Hepatocarcinoma-Binding and Internalizing Peptide

Screening and identification of a specific peptide binding to breast cancer cells from a phage-displayed peptide library

Screening and identification of a specific peptide binding to cervical cancer cells from a phage-displayed peptide library

In vitro panning of a targeting peptide to hepatocarcinoma from a phage display peptide library.

Screening for Molecular Markers for Early Diagnosis of Lung Cancer by Bacteriphage Display

Screening and Identification of a Specific Peptide Binding to Hepatocellular Carcinoma Cells from a Phage Display Peptide Library

Identification and Localization of Hepatocarcinoma-Specific Adhesion Peptide

Identification of stem-like cells in non-small cell lung cancer cells with specific peptides.

Identifying a Membrane-Type 2 Matrix Metalloproteinase-Targeting Peptide for Human Lung Cancer Detection and Targeting Chemotherapy with Functionalized Mesoporous Silica

Identification of a specific peptide binding to colon cancer cells from a phage-displayed peptide library

Lung Cancer-Targeting Peptides with Multi-subtype Indication for Combinational Drug Delivery and Molecular Imaging

Screening and Characterization of Multi-Peptide Binding Specifically to Hepatocellular Carcinoma Cells by Phage Peptide Library